Bayer 2012 Profits Impacted by Yaz and Yasmin Lawsuits

Published August 23, 2012 on LawsuitInformation.org

It has been reported that Bayer, the German pharmaceutical giant responsible for the development of Yaz and Yasmin, the health threatening birth control pills of ill repute, has created what is essentially a savings account in the amount of 500 million euros for the purpose of future Yaz and Yasmin lawsuits.

In a study conducted by the U.S. Food and Drug Administration (FDA) of Yaz and Yasmin, the FDA uncovered the high risk of blood clot development and a number of other serious cardiovascular conditions women were exposed to developing through the use of Yaz or Yasmin. In light of this discovery, the pharmaceutical company Bayer is clearly preparing for a storm of legal claims regarding Yaz and Yasmin in the future.

In July 2012, in response to the large number of Yaz and Yasmin lawsuits, Bayer accepted a settlement totaling $402.6 million. The German company paid this amount in order to settle approximately a third of the total Yaz and Yasmin lawsuits currently filed against them. There are currently 6,000 claims launched against Bayer in regards to the pharmaceutical company’s failure to inform and warn about the severe adverse side affects of using Yaz and Yasmin.

If you suffered from a blood clot or other adverse cardiovascular health condition, justice is due especially in the case of a large pharmaceutical company disregarding consumer protection, using deceptive marketing strategies, and releasing a defective drug on the market, all to bring in profits. Receive expert legal counsel from Carey Danis & Lowe.

References: Pharmaceutical litigation, Yaz/Yasmin
Tags: , , , , , , ,